New Zealand becomes the second country after Australia to authorize pharmaceutical-grade MDMA for severe post-traumatic stress disorder, with Medsafe allowing two psychiatrists to prescribe it alongside psychotherapy in controlled clinical settings.
Source:
AFP via France 24